These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21821871)

  • 1. The importance of studying history: lessons learnt from a trial of tacrolimus in myasthenia gravis.
    Benatar M; Sanders D
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):945. PubMed ID: 21821871
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
    Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
    Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
    Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M
    Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis.
    Yoshikawa H; Kiuchi T; Saida T; Takamori M
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):970-7. PubMed ID: 21784757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tacrolimus (FK506) in the treatment of prednisone-resistant myasthenia gravis. Preliminary results of 20 cases].
    Ponseti JM; Fort JM; Espin E; Armengol M
    Med Clin (Barc); 2002 Feb; 118(3):117. PubMed ID: 11825555
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials for myasthenia gravis: a historical perspective.
    Kaminski HJ; Alnosair E; Algahtani RM
    Ann N Y Acad Sci; 2018 Feb; 1413(1):5-10. PubMed ID: 29377153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
    Sanders DB; Aarli JA; Cutter GR; Jaretzki A; Kaminski HJ; Phillips LH
    Neurology; 2006 Mar; 66(6):954-5; author reply 954-5. PubMed ID: 16567729
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis.
    Wang L; Zhang S; Xi J; Li W; Zhou L; Lu J; Lu J; Zhang T; Zhao C
    J Neurol; 2017 Nov; 264(11):2191-2200. PubMed ID: 28921038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of low-dose FK506 in the treatment of Myasthenia gravis--a randomized pilot study.
    Nagane Y; Utsugisawa K; Obara D; Kondoh R; Terayama Y
    Eur Neurol; 2005; 53(3):146-50. PubMed ID: 15900097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A child with generalized myasthenia gravis successfully treated with tacrolimus].
    Goto T; Mori M; Yamagata T; Mizuguchi M; Momoi MY
    No To Hattatsu; 2007 Jul; 39(4):300-3. PubMed ID: 17633089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tacrolimus in Osserman grade III and Osserman grade IV Myasthenia Gravis.
    Zhao LN; Liang Y; Fang XJ; Liu XM; Jiang QL; Wang SS; She SF; Cao M
    Clin Neurol Neurosurg; 2018 Oct; 173():70-76. PubMed ID: 30092406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Cervera C; Armengol M
    Neurology; 2005 May; 64(9):1641-3. PubMed ID: 15883336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus monotherapy: a promising option for ocular myasthenia gravis.
    Yagi Y; Sanjo N; Yokota T; Mizusawa H
    Eur Neurol; 2013; 69(6):344-5. PubMed ID: 23549260
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of a 2-year-old girl with intractable myasthenia gravis using tacrolimus.
    Kakisaka Y; Haginoya K; Yokoyama H; Ishitobi M; Wakusawa K; Sato I; Togashi N; Kitamura T; Fukuyo N; Yoshihara Y; Iinuma K
    Brain Dev; 2006 Sep; 28(8):534-6. PubMed ID: 16564661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus in refractory patients with myasthenia gravis: coadministration and tapering of oral prednisolone.
    Shimojima Y; Matsuda M; Gono T; Ishii W; Tokuda T; Ikeda S
    J Clin Neurosci; 2006 Jan; 13(1):39-44. PubMed ID: 16307880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular myasthenia gravis patients following the administration of tacrolimus and steroids.
    Omata T; Fukui K; Kodama K; Watanabe Y; Aoyama H; Fujii K; Shimojo N
    J Neurol Sci; 2019 Jan; 396():30-32. PubMed ID: 30399462
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of myasthenia gravis with tacrolimus.
    Evoli A; Di Schino C; Marsili F; Punzi C
    Muscle Nerve; 2002 Jan; 25(1):111-4. PubMed ID: 11754194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies.
    Lin PT; Martin BA; Weinacker AB; So YT
    Muscle Nerve; 2006 Mar; 33(3):433-5. PubMed ID: 16116645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current concept and perspective of immunotherapy for myasthenia gravis: tacrolimus and cyclosporin].
    Yokoyama K
    Nihon Rinsho; 2008 Jun; 66(6):1158-64. PubMed ID: 18540363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Gamez J; Armengol M
    Curr Med Res Opin; 2006 May; 22(5):885-95. PubMed ID: 16709310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.